1. Home
  2. CRIS vs XBP Comparison

CRIS vs XBP Comparison

Compare CRIS & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • XBP
  • Stock Information
  • Founded
  • CRIS 2000
  • XBP N/A
  • Country
  • CRIS United States
  • XBP United Kingdom
  • Employees
  • CRIS N/A
  • XBP N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • XBP Business Services
  • Sector
  • CRIS Health Care
  • XBP Consumer Discretionary
  • Exchange
  • CRIS Nasdaq
  • XBP Nasdaq
  • Market Cap
  • CRIS 32.8M
  • XBP 31.2M
  • IPO Year
  • CRIS 2000
  • XBP N/A
  • Fundamental
  • Price
  • CRIS $3.22
  • XBP $1.06
  • Analyst Decision
  • CRIS Strong Buy
  • XBP
  • Analyst Count
  • CRIS 3
  • XBP 0
  • Target Price
  • CRIS $23.00
  • XBP N/A
  • AVG Volume (30 Days)
  • CRIS 39.9K
  • XBP 29.7K
  • Earning Date
  • CRIS 02-14-2025
  • XBP 11-12-2024
  • Dividend Yield
  • CRIS N/A
  • XBP N/A
  • EPS Growth
  • CRIS N/A
  • XBP N/A
  • EPS
  • CRIS N/A
  • XBP N/A
  • Revenue
  • CRIS $10,259,000.00
  • XBP $157,146,000.00
  • Revenue This Year
  • CRIS N/A
  • XBP N/A
  • Revenue Next Year
  • CRIS N/A
  • XBP N/A
  • P/E Ratio
  • CRIS N/A
  • XBP N/A
  • Revenue Growth
  • CRIS 0.44
  • XBP N/A
  • 52 Week Low
  • CRIS $2.86
  • XBP $0.79
  • 52 Week High
  • CRIS $17.49
  • XBP $4.33
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 47.34
  • XBP 50.51
  • Support Level
  • CRIS $3.05
  • XBP $0.97
  • Resistance Level
  • CRIS $3.55
  • XBP $1.10
  • Average True Range (ATR)
  • CRIS 0.24
  • XBP 0.06
  • MACD
  • CRIS 0.03
  • XBP -0.00
  • Stochastic Oscillator
  • CRIS 47.53
  • XBP 64.29

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About XBP XBP Europe Holdings Inc.

XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.

Share on Social Networks: